NO20011173L - Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer - Google Patents

Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Info

Publication number
NO20011173L
NO20011173L NO20011173A NO20011173A NO20011173L NO 20011173 L NO20011173 L NO 20011173L NO 20011173 A NO20011173 A NO 20011173A NO 20011173 A NO20011173 A NO 20011173A NO 20011173 L NO20011173 L NO 20011173L
Authority
NO
Norway
Prior art keywords
fats
preparations
methods
intestinal absorption
increasing intestinal
Prior art date
Application number
NO20011173A
Other languages
English (en)
Norwegian (no)
Other versions
NO20011173D0 (no
Inventor
David W Yesair
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Publication of NO20011173D0 publication Critical patent/NO20011173D0/no
Publication of NO20011173L publication Critical patent/NO20011173L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004—Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20011173A 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer NO20011173L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08
PCT/US1999/020427 WO2000013689A1 (en) 1998-09-08 1999-09-07 Methods and compositions for increasing intestinal absorption of fats

Publications (2)

Publication Number Publication Date
NO20011173D0 NO20011173D0 (no) 2001-03-07
NO20011173L true NO20011173L (no) 2001-05-08

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20011173A NO20011173L (no) 1998-09-08 2001-03-07 Fremgangsmåter og preparater for å öke tarmabsorpsjon av fettstoffer

Country Status (13)

Country Link
US (1) US6426069B1 (cg-RX-API-DMAC10.html)
EP (1) EP1119360B1 (cg-RX-API-DMAC10.html)
JP (1) JP4700193B2 (cg-RX-API-DMAC10.html)
CN (1) CN1321089A (cg-RX-API-DMAC10.html)
AT (1) ATE347371T1 (cg-RX-API-DMAC10.html)
AU (1) AU771901B2 (cg-RX-API-DMAC10.html)
CA (1) CA2343116C (cg-RX-API-DMAC10.html)
DE (1) DE69934325T2 (cg-RX-API-DMAC10.html)
IL (2) IL141801A0 (cg-RX-API-DMAC10.html)
NO (1) NO20011173L (cg-RX-API-DMAC10.html)
NZ (1) NZ510536A (cg-RX-API-DMAC10.html)
WO (1) WO2000013689A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200102268B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434593B1 (en) * 2001-10-11 2017-03-29 Biomolecular Products, Inc. MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
EP1350435B1 (en) 2002-04-05 2010-12-22 Societe Des Produits Nestle S.A. Compositions and methods for promoting lipid assimilation in pets
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
ES2581184T3 (es) * 2003-01-31 2016-09-01 Childrens Hospital Los Angeles Composiciones orales de fenretinida que tienen mayor biodisponibilidad y métodos de uso de las mismas
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
CN103179990B (zh) * 2010-10-22 2015-02-04 学校法人福冈大学 应用了对胃上皮性肿瘤(腺瘤、胃癌)的诊断有用的白色不透明物质的内窥镜观察法及诊断能力改善组合物
CA2817957C (en) * 2010-11-15 2016-05-10 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421B2 (en) 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
CN118416114A (zh) * 2024-01-12 2024-08-02 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
ES2071332T3 (es) 1990-08-13 1995-06-16 David W Yesair Particulas coloidales de lipidos mixtos-bicarbonato para administrar farmacos o calorias.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
EP0835097B1 (en) * 1995-06-06 2001-08-29 Biomolecular Products, Inc. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
WO1998010776A1 (en) * 1996-09-11 1998-03-19 Shanahan Prendergast Elizabeth Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms

Also Published As

Publication number Publication date
NO20011173D0 (no) 2001-03-07
CA2343116A1 (en) 2000-03-16
JP2002524417A (ja) 2002-08-06
NZ510536A (en) 2003-07-25
JP4700193B2 (ja) 2011-06-15
WO2000013689A1 (en) 2000-03-16
EP1119360B1 (en) 2006-12-06
EP1119360A4 (en) 2003-06-04
DE69934325T2 (de) 2007-07-05
AU771901B2 (en) 2004-04-08
US6426069B1 (en) 2002-07-30
ATE347371T1 (de) 2006-12-15
AU5705299A (en) 2000-03-27
IL141801A0 (en) 2002-03-10
DE69934325D1 (de) 2007-01-18
IL141801A (en) 2009-02-11
EP1119360A1 (en) 2001-08-01
CN1321089A (zh) 2001-11-07
ZA200102268B (en) 2001-09-19
CA2343116C (en) 2008-11-18

Similar Documents

Publication Publication Date Title
NO973489D0 (no) Stabilisert gassemulsjon inneholdende fosfolipid til kontrastforbedring ved ultralydundersökelser
MX9801159A (es) Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
IS5566A (is) Afurðir úr karótínsskyldum fituefnahlutum sæbjúgna og aðferðir við notkun þeirra
EP1435946B8 (en) Linked biaryl compounds
NO20011173D0 (no) FremgangsmÕter og preparat for Õ øke tarmabsorpsjon av fettstoffer
DK0892035T3 (da) Flerfaseemulsion og fremgangsmåde til fremstilling heraf
DE60136490D1 (de) Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
HUP0101378A3 (en) Method for enhancing presentation of text
DK1303632T3 (da) Galactomannan-oligosaccharid og fremgangsmåde til fremstilling samt anvendelse heraf
DE69628489D1 (de) Verfahren zur Herstellung von RTV-Einkomponenten-Siliconelastomerzusammensetzungen
NO20024722L (no) Stivelses-subtyper og lipid metabolisme
EP0735102A3 (en) Process for making one-component RTV silicone compositions
EP0790060A4 (en) ACTIVE INGREDIENT FOR IMPROVED FATTY CHANGE
AU2002367430A1 (en) Fat and oil compositions for decreasing blood lipid
WO2005016277A3 (en) Arylsulfonamidobenzylic compounds
NO20005548L (no) Mykobakterieinhibitorer
WO2000027429A3 (en) Vaccine against papillomatous digital dermatitis (pdd)
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
AU2000265943A1 (en) Education assisting system having respective curriculums for lecturees through internet
DE69506765D1 (de) Zusammensetzung gegen Fettbleichen und dieses enthaltende Laurinfett und Schokolade
UA40878A (uk) Спосіб правосторонньої геміколектомії
UA25443A (uk) Спосіб визhачеhhя життєздатhості тоhкої кишки
FR2752729B1 (fr) Appareil de relaxation sexuelle automatisee
ITRM20020129A1 (it) Metodo per l'aggiornamento interattivo delle pagine teletext e relativo apparato.
GB0119873D0 (en) Compositions for aiding the removal of lipid or fat and control of cholesterol comprising chitosan and method of using same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application